Literature DB >> 32209020

Polymorphisms rs763110 in FASL is linked to hepatitis C virus infection among high-risk populations.

P Huang1,2, C H Wang2, L Y Zhuo1, X S Xia3, S Yang4, J W Zhang5, H Z Fan6, J J Wu1, R Yu1, M Yue7,8, Y Zhang1,2.   

Abstract

BACKGROUND: The Fas cell surface death receptor (FAS) and Fas ligand (FASL) can participate in the apoptosis of immune cells and target cells infected with a virus through the FAS-FASL signalling pathway. The decoy receptor 3 (DCR3) can competitively inhibit the binding of FAS to FASL. Our aim is to investigate the effect of single nucleotide polymorphisms (SNPs) in FAS, FASL and DCR3 on hepatitis C virus (HCV) infection.
METHODS: Four SNPs (rs763110 in FASL, rs1324551 and rs2234767 in FAS and rs2257440 in DCR3) were genotyped in 1495 controls free of HCV, 522 individuals with spontaneous HCV clearance and 732 patients with hepatitis C virus infection. The RegulomeDB database and RNAfold web servers were used to explore potential biological functions of SNPs.
RESULTS: FASL rs763110 was associated with susceptibility to HCV infection, and not to CHC. The odds ratio (95% confidence interval) of HCV infection in high-risk populations carrying FASL rs763110-TT was 1.82 (1.36-2.51, P < 0.001) compared to that of CC genotypes and 1.93 (1.43-2.60, P < 0.001) higher than that of CC + CT genotypes. Based on computer simulation, FASL rs763110-T may affect the transcription of mRNA by affecting the binding of a transcription factor, leading to structural changes in mRNA.
CONCLUSION: The genetic variant in FASL is linked with HCV infection, but not to spontaneous HCV clearance.

Entities:  

Keywords:  Hepatitis C Virus; decoy receptor 3; fas ligand; fas receptor; single nucleotide polymorphisms

Mesh:

Substances:

Year:  2020        PMID: 32209020     DOI: 10.1080/09674845.2020.1747182

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  2 in total

1.  Genetic Variants in TNFSF4 and TNFSF8 Are Associated With the Risk of HCV Infection Among Chinese High-Risk Population.

Authors:  Zuqiang Fu; Weihua Cai; Jianguo Shao; Hong Xue; Zhijun Ge; Haozhi Fan; Chen Dong; Chunhui Wang; Jinwei Zhang; Chao Shen; Yun Zhang; Peng Huang; Ming Yue
Journal:  Front Genet       Date:  2021-03-25       Impact factor: 4.599

2.  Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review).

Authors:  Ying-Shuang Li; Hua-Cheng Ren; Jian-Hua Cao
Journal:  Int J Oncol       Date:  2022-03-02       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.